Stock 348 CHINA HEALTHWISE HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials China Healthwise Holdings Limited

Equities

348

KYG2120E1290

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
0.063 HKD +5.00% Intraday chart for China Healthwise Holdings Limited +21.15% +53.66%
Mar. 26 China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 21 China Healthwise to Widen Losses in 2023 MT

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 511.3 519.8 282.4 177.2 215.7 145.6
Enterprise Value (EV) 1 537 496.5 254.7 145.8 205 176.8
P/E ratio -1.76 x -2.26 x -1.76 x -7.07 x -2.09 x -2.68 x
Yield - - - - - -
Capitalization / Revenue 1.6 x 0.76 x 0.68 x 1.29 x 1.27 x 1.03 x
EV / Revenue 1.68 x 0.73 x 0.62 x 1.06 x 1.21 x 1.24 x
EV / EBITDA -3.58 x -7.23 x -15.6 x -2.87 x -2.72 x -4.63 x
EV / FCF -8.85 x -13.4 x -1.7 x 1.63 x 125 x -1.56 x
FCF Yield -11.3% -7.45% -58.9% 61.3% 0.8% -64.1%
Price to Book 1.3 x 1.32 x 0.87 x 0.6 x 1.12 x 1.05 x
Nbr of stocks (in thousands) 710,131 852,131 784,441 770,481 770,481 770,481
Reference price 2 0.7200 0.6100 0.3600 0.2300 0.2800 0.1890
Announcement Date 7/28/17 7/27/18 4/28/20 4/21/21 4/28/22 4/26/23
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 319.2 682.5 413.3 137.9 170.1 142.1
EBITDA 1 -150 -68.67 -16.34 -50.75 -75.48 -38.2
EBIT 1 -167.9 -88.73 -18.05 -52.31 -75.78 -38.39
Operating Margin -52.6% -13% -4.37% -37.94% -44.56% -27.02%
Earnings before Tax (EBT) 1 -263.8 -194.7 -168.4 -72.93 -100.6 -56.4
Net income 1 -241.9 -186.1 -165.8 -25.22 -103 -54.27
Net margin -75.79% -27.27% -40.12% -18.3% -60.59% -38.21%
EPS 2 -0.4088 -0.2694 -0.2045 -0.0325 -0.1337 -0.0704
Free Cash Flow 1 -60.69 -37 -150.1 89.43 1.64 -113.4
FCF margin -19.01% -5.42% -36.33% 64.88% 0.96% -79.8%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 7/28/17 7/27/18 4/28/20 4/21/21 4/28/22 4/26/23
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 25.7 - - - - 31.2
Net Cash position 1 - 23.3 27.7 31.4 10.8 -
Leverage (Debt/EBITDA) -0.1712 x - - - - -0.8159 x
Free Cash Flow 1 -60.7 -37 -150 89.4 1.64 -113
ROE (net income / shareholders' equity) -61.7% -70.1% -20.9% -22.2% -42.1% -32.7%
ROA (Net income/ Total Assets) -16.5% -9.62% -0.76% -6.33% -12.7% -7.97%
Assets 1 1,468 1,934 21,783 398.4 814.1 680.7
Book Value Per Share 2 0.5500 0.4600 0.4200 0.3800 0.2500 0.1800
Cash Flow per Share 2 0.0600 0.0800 0.0600 0.0500 0.0500 0.0200
Capex 1 16.5 6.31 4.36 4.52 0.36 0.63
Capex / Sales 5.18% 0.92% 1.06% 3.28% 0.21% 0.44%
Announcement Date 7/28/17 7/27/18 4/28/20 4/21/21 4/28/22 4/26/23
1HKD in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
CHINA HEALTHWISE HOLDINGS LIMITED Stock China Healthwise Holdings Limited
+53.66% 6.2M
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.39% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.38% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+0.49% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
GALENICA AG Stock Galenica AG
-2.61% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+22.08% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 348 Stock
  4. Financials China Healthwise Holdings Limited